Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$301,191,670
-$34,046,373 QoQ
Shares Held
2,161,094
-20.9% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.337557736961.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6624422630389979.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,020,049,253 across 14 Drug Manufacturers - General names. GILD ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,866,854 | $1,717,076,303 | |
| 2 | JNJ |
Johnson & Johnson
|
3,429,005 | $838,185,982 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
9,151,211 | $555,020,947 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,789,757 | $455,869,869 | |
| 5 | PFE |
Pfizer Inc
|
15,508,999 | $435,492,691 | |
| 6 | ABBV |
AbbVie Inc.
|
1,523,989 | $331,452,367 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,161,094 | $301,191,670 | |
| 8 | AMGN |
Amgen Inc
|
642,962 | $226,226,179 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $301,191,670 | 2,161,094 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $335,238,043 | 2,731,286 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $315,361,434 | 2,841,094 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $309,342,709 | 2,790,139 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $276,877,454 | 2,471,017 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $281,873,243 | 3,051,567 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $214,765,550 | 2,561,612 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $207,917,527 | 3,030,426 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $167,985,470 | 2,293,317 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $201,691,002 | 2,489,705 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $173,199,004 | 2,311,169 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $167,542,241 | 2,173,897 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $197,348,376 | 2,378,551 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $202,687,643 | 2,360,951 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $154,775,953 | 2,508,931 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $152,090,860 | 2,460,619 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $136,869,535 | 2,302,263 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $137,897,717 | 1,899,156 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $111,067,926 | 1,590,092 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $135,295,783 | 1,964,795 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $93,356,871 | 1,444,482 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $65,988,189 | 1,132,650 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $61,084,951 | 966,687 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $74,843,308 | 972,749 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $79,581,646 | 1,064,495 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||